StockData
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. (KRYS) stock

KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$298.55+0.65 (+0.22%)

Close on Nov 17, 2026Market cap $8.84BP/E 37.4Yield –

Krystal Biotech total assets

Total assets on the balance sheet at the end of each period.

Krystal Biotech's total assets was $1.50B at Jun 30, 2026. For fiscal 2025 it was $1.33B, up 26.3% from the year before. The highest annual figure on record is $1.33B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.33B+26.3%
FY2024Dec 31, 2024$1.06B+29.0%
FY2023Dec 31, 2023$818.36M+46.5%
FY2022Dec 31, 2022$558.45M-10.8%
FY2021Dec 31, 2021$626.30M+101.5%
FY2020Dec 31, 2020$310.84M+48.7%
FY2019Dec 31, 2019$209.02M+80.0%
FY2018Dec 31, 2018$116.12M+131.7%
FY2017Dec 31, 2017$50.11M+2196.7%
FY2016Dec 31, 2016$2.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.50B+31.8%
Q1 FY2026Mar 31, 2026$1.40B+30.0%
Q4 FY2025Dec 31, 2025$1.33B+26.3%
Q3 FY2025Sep 30, 2025$1.24B+26.2%
Q2 FY2025Jun 30, 2025$1.14B+24.1%
Q1 FY2025Mar 31, 2025$1.07B+25.9%
Q4 FY2024Dec 31, 2024$1.06B+29.0%
Q3 FY2024Sep 30, 2024$982.32M+24.3%
Q2 FY2024Jun 30, 2024$917.66M+34.2%
Q1 FY2024Mar 31, 2024$853.30M+60.4%
Q4 FY2023Dec 31, 2023$818.36M+46.5%
Q3 FY2023Sep 30, 2023$790.35M+37.1%
Q2 FY2023Jun 30, 2023$684.03M+13.8%
Q1 FY2023Mar 31, 2023$531.85M-13.8%
Q4 FY2022Dec 31, 2022$558.45M-10.8%
Q3 FY2022Sep 30, 2022$576.38M+27.8%
Q2 FY2022Jun 30, 2022$601.32M+35.6%
Q1 FY2022Mar 31, 2022$616.87M+39.2%
Q4 FY2021Dec 31, 2021$626.30M+101.5%
Q3 FY2021Sep 30, 2021$451.10M+44.8%
Q2 FY2021Jun 30, 2021$443.56M+39.4%
Q1 FY2021Mar 31, 2021$443.02M+116.0%
Q4 FY2020Dec 31, 2020$310.84M+48.7%
Q3 FY2020Sep 30, 2020$311.45M+45.4%
Q2 FY2020Jun 30, 2020$318.15M+55.1%
Q1 FY2020Mar 31, 2020$205.13M+77.3%
Q4 FY2019Dec 31, 2019$209.02M+80.0%
Q3 FY2019Sep 30, 2019$214.23M+293.4%
Q2 FY2019Jun 30, 2019$205.16M+345.7%
Q1 FY2019Mar 31, 2019$115.70M+141.8%
Q4 FY2018Dec 31, 2018$116.12M+131.7%
Q3 FY2018Sep 30, 2018$54.45M+3.4%
Q2 FY2018Jun 30, 2018$46.03M+2009.5%
Q1 FY2018Mar 31, 2018$47.85M–
Q4 FY2017Dec 31, 2017$50.11M–
Q3 FY2017Sep 30, 2017$52.67M–
Q4 FY2016Dec 31, 2016$2.18M–

More Krystal Biotech figures

See a number that looks wrong?